Clinical Trial Update: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab plus paclitaxel, carboplatin, and bevacizumab versus control in newly diagnosed ovarian, fallopian tube, or primary periton…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Neoplasms

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-02-17